announcement about cantx, page-21

As per the announcement

Prof Mor set NRT the ultimate test by setting out to replicate as much as possible the clinical situation.

Trx-1 is the first drug to be effective across the full spectrum of ovarian cancer cells at the same dosage being enough evidence to progress the drug into the clinic.

As I have stated on many occasions NRT have put together the brightest and smartest people in the field of cancer and delivery systems to give their drugs the best chance of success.

I truly wish them all the success for the good of man kind!